Malignant signature may help identify patients likely to respond to therapy

A molecular signature that helps account for the aggressive behaviour of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalised approach to treatment for a variety of solid tumours that are currently resistant to therapies, was published 6 September in the advance online edition of Nature Medicine...

Read the whole article on

More from